$0.800
0.000 (0.00%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Phio Pharmaceuticals Corp (PHIO) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting PHIO is Strong sell.
Phio Pharmaceuticals Corp (PHIO) 20-Day simple moving average is 0.88, while Phio Pharmaceuticals Corp (PHIO) share price is $—, making it Sell.
Phio Pharmaceuticals Corp (PHIO) 60-Day simple moving average is 1.00, while Phio Pharmaceuticals Corp (PHIO) share price is $—, making it Sell.
Technical Analysis for PHIO
AI Technical PHIOAs of 2026-11-07, the technical board for Phio Pharmaceuticals Corp (PHIO) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $0.80 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 33.134, MACD stands at -0.039 (Sell), Stochastic %K stands at 17.505 (Buy), Stochastic %D stands at 22.323 and CCI stands at -254.252 (Buy).
PHIO trades below the 60-day SMA (1.00) and below the 200-day SMA (1.08). Immediate resistance sits at Classic R1 0.94, then R2 1.01. Support sits at Classic S1 0.77, then S2 0.67.
Phio Pharmaceuticals Corp (PHIO) Support & Resistance Level
Phio Pharmaceuticals Corp (PHIO) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 33.134 |
| STOCHk_14_3_3 | 17.505 |
| STOCHd_14_3_3 | 22.323 |
| CCI_20 | -254.252 |
| AO_5_34 | -0.081 |
| MOM_10 | -0.051 |
| MACD_12_26_9 | -0.039 |
Phio Pharmaceuticals Corp (PHIO) Relative Strength Index (RSI_14) is 33.134, creating a Neutral signal.
Phio Pharmaceuticals Corp (PHIO) Stochastic %K is 17.505, creating a Buy signal.
Phio Pharmaceuticals Corp (PHIO) Stochastic %D is 22.323, creating a Neutral signal.
Phio Pharmaceuticals Corp (PHIO) CCI_20 is -254.252, creating a Buy signal.
Phio Pharmaceuticals Corp (PHIO) Awesome Oscillator (AO) is -0.081, creating a Sell signal.
Phio Pharmaceuticals Corp (PHIO) Momentum (MOM) is -0.051, creating a Sell signal.
Phio Pharmaceuticals Corp (PHIO) Moving Average Convergence Divergence (MACD) is -0.039, creating a Sell signal.
Phio Pharmaceuticals Corp (PHIO) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.851 | Sell |
| MA_10 | 0.863 | Sell |
| MA_20 | 0.881 | Sell |
| MA_60 | 0.999 | Sell |
| MA_200 | 1.082 | Sell |
| MA_250 | 1.103 | Sell |
Phio Pharmaceuticals Corp (PHIO) 5-Day simple moving average is 0.851, while Phio Pharmaceuticals Corp (PHIO) share price is $, making it a Sell.
Phio Pharmaceuticals Corp (PHIO) 10-Day simple moving average is 0.863, while Phio Pharmaceuticals Corp (PHIO) share price is $, making it a Sell.
Phio Pharmaceuticals Corp (PHIO) 20-Day simple moving average is 0.881, while Phio Pharmaceuticals Corp (PHIO) share price is $, making it a Sell.
Phio Pharmaceuticals Corp (PHIO) 60-Day simple moving average is 0.999, while Phio Pharmaceuticals Corp (PHIO) share price is $, making it a Sell.
Phio Pharmaceuticals Corp (PHIO) 200-Day simple moving average is 1.082, while Phio Pharmaceuticals Corp (PHIO) share price is $, making it a Sell.
Phio Pharmaceuticals Corp (PHIO) 250-Day simple moving average is 1.103, while Phio Pharmaceuticals Corp (PHIO) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.